Dupont Adjusts The Chemistry

CHARLES HOLLIDAY IS SURE WASTING no time putting his mark on chemical giant DuPont. The CEO since February, Holliday announced on Apr. 7 an organizational overhaul that will let the company focus on faster-growing businesses. This reorganization could signal bigger changes ahead, including possible spin-offs. Bear Stearns analyst Jeffrey Cianci figures the company may sell its Conoco oil and gas unit to fund investment in its life-sciences division, which includes agricultural biotech and pharmaceutical businesses. Last year, DuPont did deals worth more than $3 billion to build up life-sciences operations, and Holliday calls it the company "centerpiece."

To continue reading this article you must be a Bloomberg Professional Service Subscriber.